Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neuroderm Ltd Ord Sh (NDRM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,023,698
  • Shares Outstanding, K 26,350
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,500 K
  • 36-Month Beta 0.77
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.97
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.56
  • Most Recent Earnings -0.25 on 05/11/17
  • Next Earnings Date 11/09/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate -0.49
  • Number of Estimates 2
  • High Estimate -0.42
  • Low Estimate -0.56
  • Prior Year -0.42
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.80 +0.13%
on 09/19/17
38.95 -0.26%
on 10/17/17
unch (unch)
since 09/15/17
3-Month
30.70 +26.55%
on 07/18/17
38.95 -0.26%
on 10/17/17
+7.60 (+24.32%)
since 07/17/17
52-Week
15.20 +155.59%
on 12/01/16
38.95 -0.26%
on 10/17/17
+21.50 (+123.92%)
since 10/17/16

Most Recent Stories

More News
Mitsubishi Tanabe Pharma Corporation Completes Acquisition of NeuroDerm

NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced today the completion of the previously announced...

NDRM : 38.85 (-0.13%)
MTZPY : 17.7850 (+0.54%)
NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma Corporation

NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, announced that at NeuroDerm's extraordinary general...

NDRM : 38.85 (-0.13%)
MTZPY : 17.7850 (+0.54%)
Viceroy Research Believes Mitsubishi Tanabe's $1.1B Acquisition of Neuroderm Will Result in Complete Writeoff

Viceroy Research (Viceroy) today released a detailed analysis of Mitsubishi Tanabe's (TYO: 4508) potential acquisition of Neuroderm (NASDAQ: NDRM). Viceroy has meticulously researched the...

NDRM : 38.85 (-0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade NDRM with:

Business Summary

Neuroderm Ltd. is a clinical-stage pharmaceutical company. It is developing next-generation treatments for central nervous system (CNS) disorders. The Company develops liquid levodopa (LD), which is a treatment for Parkinson's disease (PD). Its product pipelines includes ND0612L for moderate PD, ND0612H...

See More

Key Turning Points

2nd Resistance Point 38.98
1st Resistance Point 38.92
Last Price 38.85
1st Support Level 38.82
2nd Support Level 38.78

See More

52-Week High 38.95
Last Price 38.85
Fibonacci 61.8% 29.88
Fibonacci 50% 27.08
Fibonacci 38.2% 24.27
52-Week Low 15.20

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar